Medicine and Dentistry
Urokinase Receptor
79%
Tetraxetan
64%
Polyethylene Terephthalate
58%
Neoplasm
57%
Xenograft
37%
Copper 64
37%
Radioactive Tracer
35%
Receptor
35%
Cancer Surgery
34%
Glioblastoma
33%
Tumor Invasion
31%
Biopsy Technique
29%
Intracranial Tumor
29%
Sentinel Node
29%
Lutetium 177
29%
Oral Cancer
29%
Targeted Radionuclide Therapy
29%
Indocyanine Green
29%
Plasminogen Activator
29%
Urokinase
29%
Prostate Cancer
29%
Head and Neck Cancer
29%
Sentinel Lymph Node
17%
Optical Imaging
16%
Cancer Model
16%
Receptor Expression
16%
Keyphrases
AE105
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
88%
Receptor Targets
64%
Near-infrared Fluorescence Imaging
47%
Cancer Invasion
31%
Peptide-based
31%
Tracer Imaging
29%
Head-and-neck Cancer
29%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
29%
Urokinase
29%
NIR-II Probe
29%
Plasminogen Receptor
29%
Orthotopic Xenograft Model
29%
Quantitative PET
29%
Image-guided Surgery
29%
Lutetium-177 (177Lu)
29%
Indocyanine Green
29%
In Vivo Testing
29%
Targeted Radionuclide Therapy
29%
Orthotopic Glioma
23%
Receptor Expression
16%
